Percutaneous Release vs Steroid Injection for Trigger Finger
Trigger Finger
About this trial
This is an interventional treatment trial for Trigger Finger focused on measuring Trigger fingers, Trigger digits, Steroid injection, Percutaneous release
Eligibility Criteria
Inclusion Criteria:
- Participants aged 18 years and above
- Duration of symptoms :≥ 3 months
- Triggering in any of the digits of hand
- Trigger finger type II-IV based on Quinnell classification
Exclusion Criteria:
- There is prior treatment for trigger finger, or Trigger thumb
- There had been previous surgery or other hand pathology such as rheumatoid arthritis, osteoarthritis, Dupuytren's contracture and diabetic mellitus.
Sites / Locations
- Armed Police Force Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
percutaneous release
Steroid injection
Percutaneous release of A1 pulley release will be performed in the well-managed operation theater set up, using an 18 gauge hypodermic needle, after preparation of the skin and injection of 1ml 2% plain lidocaine. The proper location of the pulley will be defined using surface landmarks in each digit after waiting a few minutes to allow the anesthetic to take effect the 18 gauge needle will be longitudinally moved to keep the level of the needle parallel with the tendon grating sensation will be elucidated confirming the cut of pulley until there is no grating sensation felt and improvement of symptoms. A sterile dressing will be placed.
The steroid injection mixed with 1 ml of methyl prednisone (40mg) with 0.5 ml of 2% plain lidocaine will be inserted into the flexor tendon sheath over the A1 pulley, which will also be performed in the operation theater for patient safety.